Article Figures & Tables
Figures
Figure 1: Unadjusted time to death among patients with bare-metal stents and those with drug-eluting stents. Top panel: all patients (n = 6440); middle panel: patients with acute coronary syndromes (n = 4864); bottom panel: patients with non-acute coronary syndromes (n = 1576).
Figure 2: Unadjusted time to composite outcome (death or repeat revascularization) among patients with bare-metal stents and those with drug-eluting stents. Top panel: all patients (n = 6440); middle panel: patients with acute coronary syndromes (n = 4864); bottom panel: patients with non-acute coronary syndromes (n = 1576).
Figure 3: Unadjusted spline analysis of the relative risk of death (top panel) and the composite outcome of death or repeat revascularization (bottom panel) among patients with drug-eluting stents (v. those with bare-metal stents) over the 3-year follow-up period. A relative risk below 1.0 indicates a decreased risk of events among patients with drug-eluting stents. The thin lines above and below the thicker line represent 95% confidence intervals.
Figure 4: Risk-adjusted spline analysis of the relative risk of death (top panel) and the composite outcome of death or repeat revascularization (bottom panel) among patients with drug-eluting stents (v. those with bare-metal stents) over the 3-year follow-up period. A relative risk below 1.0 indicates a decreased risk of events among patients with drug-eluting stents. The thin lines above and below the thicker line represent 95% confidence intervals.
Tables
Table 1.
Table 2.
In this issue
Article tools
